MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 1,998.00
+151.00 (8.18%)
At close: Feb 13, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 4.61 billion as of February 13, 2026. Its market cap has decreased by -37.46% in one year.
Market Cap
4.61B
Enterprise Value
n/a
Revenue
583.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,998.00
Market Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 4.61B, a decrease of -77.87%. That is a compound annual growth rate of -15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.61B | 17.53% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 141.81B |
| LabGenomics | 125.09B |
| HLB bioStep | 106.69B |
| P&K Skin Research Center | 69.32B |
| C&R Research | 51.44B |
| WOOJUNG BIO | 40.48B |
| DT&CRO CO. | 35.28B |
| SLS BIO | 26.89B |